Hydrogen Sulfide: An Emerging Precision Strategy for Gas Therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34788499.
- Also identified by DOI 10.1002/adhm.202101984.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Advances in nanotechnology have enabled the rapid development of stimuli-responsive therapeutic nanomaterials for precision gas therapy. Hydrogen sulfide (H<sub>2</sub> S) is a significant gaseous signaling molecule with intrinsic biochemical properties, which exerts its various physiological effects under both normal and pathological conditions. Various nanomaterials with H<sub>2</sub> S-responsive properties, as new-generation therapeutic agents, are explored to guide therapeutic behaviors in biological milieu. The cross disciplinary of H<sub>2</sub> S is an emerging scientific hotspot that studies the chemical properties, biological mechanisms, and therapeutic effects of H<sub>2</sub> S. This review summarizes the state-of-art research on H<sub>2</sub> S-related nanomedicines. In particular, recent advances in H<sub>2</sub> S therapeutics for cancer, such as H<sub>2</sub> S-mediated gas therapy and H<sub>2</sub> S-related synergistic therapies (combined with chemotherapy, photodynamic therapy, photothermal therapy, and chemodynamic therapy) are highlighted. Versatile imaging techniques for real-time monitoring H<sub>2</sub> S during biological diagnosis are reviewed. Finally, the biosafety issues, current challenges, and potential possibilities in the evolution of H<sub>2</sub> S-based therapy that facilitate clinical translation to patients are discussed.
Medical subject headings
- Hydrogen Sulfide
- Nanostructures
- Neoplasms